摘要 |
<p>The invention relates to compounds of general formula I wherein D, E, F, G, W, Y R1, A, R9, X, B, R8 are as defined herein, and pharmaceutically acceptable salts, hydrates, or solvates thereof, for use-alone or in combination with one or more other pharmaceutically active compounds- in therapy, for treating diseases associated with deregulated angiogeneseI, such as cancer.</p> |